This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Steriline, a European manufacturer of highly specialized robotic filling machines and complete aseptic filling/finishing lines, announces a Robotic Vial Filling Machine utilizing Planar Motor technology, a magnetically levitated transport system.
The innovative solution consists of a unique platform (using technology similar to Maglev Bullet Trains) that levitates movers above a stainless surface providing 6 degrees of precise motion and zero friction. This allows for the transport of containers (vials, syringes, cartridges, etc.) from station to station in the filling and closing operation, without any mechanical components. The combination of this technology, and the use of robotics for loading and unloading, results in a highly flexible and clean platform.
“Steriline continues to lead the industry in Robotic implementations in aseptic environments with over 150 robotic systems deployed over the past decade, showing that we are early adopters of innovative technologies and capable of bringing them to commercialization,” adds James Rorke, VP of Steriline North American Operations. “The development of Planar Motor technologies in aseptic environments further pushes the envelope towards greater flexibility and increased contamination control.”
“The revision of EU GMP Annex 1 is boosting the adoption, in the pharmaceutical industry, of technologies able to improve the quality of products and the safety of operators,” affirms Federico Fumagalli, Chief Commercial Officer at Steriline. “Steriline's R&D department always looks to the future with the aim of identifying technological opportunities, such as the Planar Motor solution, to be implemented in our equipment. It is thanks to this far-sighted vision that progress is facilitated, with Steriline aiming to become an even stronger reference supplier for the pharmaceutical industry.”
Steriline will display the filling machine at Interphex April 16-18, 2024, at the Javits Center in NYC.
